Cresset Asset Management, LLC Hcw Biologics Inc. Transaction History
Cresset Asset Management, LLC
- $17.6 Billion
- Q1 2025
A detailed history of Cresset Asset Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 131,990 shares of HCWB stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
131,990
Previous 131,990
-0.0%
Holding current value
$1.02 Million
Previous $56,000
2557.14%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HCWB
# of Institutions
16Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$2.16 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.88 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.83 Million0.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$580,6460.01% of portfolio
-
J.W. Cole Advisors, Inc.53.4KShares$412,7970.02% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $277M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...